Chiral Technologies, Inc. is a subsidiary of Daicel Corporation, the global market leader in enantioselective chromatography, offering the most extensive portfolio of chiral stationary phases available on the market. Enantioselective chromatography is essential to accelerate drug discovery and development processes. Scientists in the pharmaceutical, agricultural and food industries, universities, and government agencies rely on our expertise in enantioselective chromatography to separate chiral molecules into single enantiomers in research and development departments, and QC laboratories to initiate pre-clinical trials.
Chiral Technologies serves the North and Latin American markets through Chiral Technologies Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation.
Daicel chiral columns:
Chiral Technologies' headquarters, including a state-of-the-art technical center, are located in West Chester, PA.
800 North Five Points Road
West Chester, PA 19380
TELEPHONE
(610) 594-2100
or 800 6CHIRAL
FAX
(610) 594-2325
WEB SITE
NUMBER OF EMPLOYEES
22
YEAR FOUNDED
1990
University of Rouen-Normandy Scientists Explore Eco-Friendly Sampling Approach for GC-HRMS
April 17th 2025Root exudates—substances secreted by living plant roots—are challenging to sample, as they are typically extracted using artificial devices and can vary widely in both quantity and composition across plant species.
Thermodynamic Insights into Organic Solvent Extraction for Chemical Analysis of Medical Devices
April 16th 2025A new study, published by a researcher from Chemical Characterization Solutions in Minnesota, explored a new approach for sample preparation for the chemical characterization of medical devices.